Exact Mass: 410.1859
Exact Mass Matches: 410.1859
Found 444 metabolites which its exact mass value is equals to given mass value 410.1859
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Diflorasone
Diflorasone is only found in individuals that have used or taken this drug. It is a topical corticosteroid used to treat itching and inflammation of the skin.The precise mechanism of the antiinflammatory activity of topical steroids in the treatment of steroid-responsive dermatoses, in general, is uncertain. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents
Benfuracarb
C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor
Quinaprilat
Quinaprilat is the active metabolite of quinapril. Quinapril is a prodrug and is a long-acting, non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor used in the treatment of arterial hypertension or chronic heart failure (PMID: 19761414). Prodrugs are compounds that must be metabolized in the gut or liver before they can become active. Quinaprilat functions through blocking the conversion of angiotensin I to the vasoconstrictor angiotensin II, thereby inhibiting bradykinin degradation which reduces vascular oxidative stress and endothelial activity (PMID: 15223904). It is eliminated mainly in urine. It has no teratogenic, mutagenic or carcinogenic effect. Quinaprilat is only found in individuals who have taken or consumed the drug quinapril. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Oseltamivir phosphate
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Pteroside D
Constituent of Pteridium aquilinum (bracken fern). Pteroside D is found in green vegetables and root vegetables. Pteroside D is found in green vegetables. Pteroside D is a constituent of Pteridium aquilinum (bracken fern).
Pteroside A
Pteroside A is found in green vegetables. Pteroside A is a constituent of Pteris aquilinum (bracken fern)
Scorzoside
Constituent of Scorzonera hispanica (scorzonera). Scorzoside is found in coffee and coffee products and root vegetables. Scorzoside is found in coffee and coffee products. Scorzoside is a constituent of Scorzonera hispanica (scorzonera).
Eremopetasitenin C3
Eremopetasitenin D3 is found in green vegetables. Eremopetasitenin D3 is a constituent of Petasites japonicus (sweet coltsfoot). Constituent of Petasites japonicus (sweet coltsfoot). Eremopetasitenin C3 is found in green vegetables.
Tafluprost free acid
Tafluprost free acid is only found in individuals that have used or taken Tafluprost. Tafluprost free acid is a metabolite of Tafluprost. Tafluprost free acid belongs to the family of Halogenated Fatty Acids. These are fatty acids contaning an halogen atom (Cl,F,I,Br).
Brucine N-oxide
Deoxycorticosterone sulfate
Flumethasone
Tafluprost acid
19-Monoacetyl cincassiol A
19-monoacetyl cincassiol a is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 19-monoacetyl cincassiol a can be found in chinese cinnamon, which makes 19-monoacetyl cincassiol a a potential biomarker for the consumption of this food product.
Pseudobrucine
A monoterpenoid indole alkaloid that is brucine in which the hydrogen at position 16 has been replaced by a hydroxy group.
(5a)|21,22alpha-epoxy-2-methoxy-19-methyl-(21alpha)-21,22-dihydro-16,19-seco-strychnidine-10,16-dione
11alpha,13-dihydrodehydrocostuslactone-8-O-beta-D-glucoside|11beta,13-Dihydro,8-O-beta-D-glucopyranoside-(1alpha,5alpha,6alpha,8alpha)-8-Hydroxy-4(15),11(13),10(14)-guaiatrien-12,6-olide|11betaH-11,13-dihydrodehydrocostuslactone 8-O-beta-D-glucoside
2alpha-(beta-D-glucopyranosyloxy)-5alphaH-eudesma-4(15),11(13)-dien-12,8beta-olide
4-O-acetyl-6beta,9beta-dihydroxypulchellin-2-O-isobutyrate
(12S)-15,16-epoxy-3beta,4alpha,6beta,12-tetrahydroxy-18-methoxyneocleroda-13(16),14-dien-20,19-olide
(1S,5S,6R,7S,10R)-1-hydroxy-4-methoxy-5-methylbutanoyloxy-2,9-dioxoxanth-11-en-6,12-olide
16,19-Secostrychnidine-10,16-dione, 21,22-epoxy-21,22-dihydro-4-methoxy-19-methyl-, (21.alpha.,22.alpha.)-
8beta-angeloyloxy-3beta,10beta-epoxy-1beta,15-dihydroxy-3alpha-methoxy-4beta-H-germacran-11(13)-en-6alpha,12-olide|helivypolide I
N1-methoxycarbonyl-12-hydroxy-Delta16,17-kopsinine
12-hydroxy-2,16-dimethoxy-strychnidin-10-one|Rindlin
(1R*,2R*,3S*,5S*,6S*,7S*,10S*)-2,3,14-triacetoxy-1,10-epoxybicyclogermacr-4(15)-en-5-ol
1,3,5-Tri-Ac-8-(1-Hydroxypropyl)-2-(2-penten-4-ynyl)-3,5,6-oxocanetriol
1,3,6-Tri-Ac-8-(1-Hydroxypropyl)-2-(2-penten-4-ynyl)-3,5,6-oxocanetriol
4,14,15-triacetoxypseudoguaian-12,6-olide|rudbeckolide
dunnianoside I|p-[(1S,4R)-1,2,2-trimethyl-4-O-beta-D-glucopyranosylcyclopentyl]benzoic acid
4S,5R-12-O-beta-D-glucopyranosyl-eremophil-7(11)(Z),9-dien-8-one-12-oic acid
alatoside G|beta-D-glucopyranosyloxyl 9-oxo-4,11(13)-eudesmadien-12-oate
1-O-hexanoyl-6-O-beta-D-xylopyranosyl-beta-D-glucopyranose|nonioside S
11-Methoxy-Vomicine|4-hydroxy-3-methoxy-19-methyl-16,19-seco-strychnidine-10,16-dione|4-Hydroxy-3-methoxy-N-methyl-sec.-pseudostrychnin
3alpha-hydroxy-1alpha,5alpha,7alpha(H)-guaia-4(15),10(14),11(13)-trien-12-oic acid beta-glucopyranosyl ester
3beta,6beta,8alpha-triacetoxy-4beta,5alpha-epoxy-1-oxogermacr-10(14)-ene
N-p-coumaroyl-N-feruloylputrescine|p-coumaroylferuloylputrescine
6beta-hydroxy-acetoxy-9beta-hydroxypullchellin-2-O-isobutirate
(19S)-17,19-epoxy-(20alphaH)-coryn-16-ene-5beta,16-dicarboxylic acid dimethyl ester|19alpha-methyl-(20alpha)-18-oxa-yohimb-16-ene-5beta,16-dicarboxylic acid dimethyl ester
dimethyl (1R,4S,12R,13S,16R)-17-oxo-5,14-diazahexacyclo[12.4.3.0^{1,13.0^{4,12.0^{6,11.0^{12,16]henicosa-6,8,10-triene-4,5-dicarboxylate
1-O-(3-methylbut-3-en-1-yl)-6-O-beta-D-glucopyranosyl-beta-D-glucopyranose|3-methyl-3-butenyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside|3-methylbut-3-enyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside|3-methylbut-3-enyl-6-O-beta-D-glucopyranosyl-beta-D-glucopyranose|3-methylbut-3-enyl6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside|nonioside A
9alpha-Hydroxy-8-desacyloxy-8beta-isovaleryloxy-melnerin A
3beta-angeloyloxy-8beta,10beta-dihydroxy-6beta-methoxyeremophilenolide
1alpha-methoxy-3alpha,15-dihydroxy-3,10-epoxy-8beta-O-methylbutanoyl-4,11(13)-germacradien, 6alpha,12-olide
[5-ethenyl-3-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl] 3,4-dihydroxy-2-methylidenebutanoate
[5-ethenyl-3-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl] 3,4-dihydroxy-2-methylidenebutanoate
Flumethasone
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XB - Corticosteroids, moderately potent, other combinations D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 2823 INTERNAL_ID 2823; CONFIDENCE standard compound
Ala Ala Ser Tyr
Ala Ala Tyr Ser
Ala Phe Ser Ser
Ala Gly Thr Tyr
Ala Gly Tyr Thr
Ala His Pro Ser
Ala His Ser Pro
Ala Pro His Ser
Ala Pro Ser His
Ala Ser Ala Tyr
Ala Ser Phe Ser
Ala Ser His Pro
Ala Ser Pro His
Ala Ser Ser Phe
Ala Ser Tyr Ala
Ala Thr Gly Tyr
Ala Thr Tyr Gly
Ala Tyr Ala Ser
Ala Tyr Gly Thr
Ala Tyr Ser Ala
Ala Tyr Thr Gly
Phe Ala Ser Ser
Phe Gly Ser Thr
Phe Gly Thr Ser
Phe Ser Ala Ser
Phe Ser Gly Thr
Phe Ser Ser Ala
Phe Ser Thr Gly
Phe Thr Gly Ser
Phe Thr Ser Gly
Gly Ala Thr Tyr
Gly Ala Tyr Thr
Gly Phe Ser Thr
Gly Phe Thr Ser
Gly His Pro Thr
Gly His Thr Pro
Gly Pro His Thr
Gly Pro Thr His
Gly Ser Phe Thr
Gly Ser Thr Phe
Gly Thr Ala Tyr
Gly Thr Phe Ser
Gly Thr His Pro
Gly Thr Pro His
Gly Thr Ser Phe
Gly Thr Tyr Ala
Gly Tyr Ala Thr
Gly Tyr Thr Ala
His Ala Pro Ser
His Ala Ser Pro
His Gly Pro Thr
His Gly Thr Pro
His Pro Ala Ser
His Pro Gly Thr
His Pro Ser Ala
His Pro Thr Gly
His Ser Ala Pro
His Ser Pro Ala
His Thr Gly Pro
His Thr Pro Gly
Pro Ala His Ser
Pro Ala Ser His
Pro Gly His Thr
Pro Gly Thr His
Pro His Ala Ser
Pro His Gly Thr
Pro His Ser Ala
Pro His Thr Gly
Pro Ser Ala His
Pro Ser His Ala
Pro Thr Gly His
Pro Thr His Gly
Quinaprilat
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Ser Ala Ala Tyr
Ser Ala Phe Ser
Ser Ala His Pro
Ser Ala Pro His
Ser Ala Ser Phe
Ser Ala Tyr Ala
Ser Phe Ala Ser
Ser Phe Gly Thr
Ser Phe Ser Ala
Ser Phe Thr Gly
Ser Gly Phe Thr
Ser Gly Thr Phe
Ser His Ala Pro
Ser His Pro Ala
Ser Pro Ala His
Ser Pro His Ala
Ser Ser Ala Phe
Ser Ser Phe Ala
Ser Thr Phe Gly
Ser Thr Gly Phe
Ser Tyr Ala Ala
Thr Ala Gly Tyr
Thr Ala Tyr Gly
Thr Phe Gly Ser
Thr Phe Ser Gly
Thr Gly Ala Tyr
Thr Gly Phe Ser
Thr Gly His Pro
Thr Gly Pro His
Thr Gly Ser Phe
Thr Gly Tyr Ala
Thr His Gly Pro
Thr His Pro Gly
Thr Pro Gly His
Thr Pro His Gly
Thr Ser Phe Gly
Thr Ser Gly Phe
Thr Tyr Ala Gly
Thr Tyr Gly Ala
Tyr Ala Ala Ser
Tyr Ala Gly Thr
Tyr Ala Ser Ala
Tyr Ala Thr Gly
Tyr Gly Ala Thr
Tyr Gly Thr Ala
Tyr Ser Ala Ala
Tyr Thr Ala Gly
Tyr Thr Gly Ala
Tafluprost acid
Diflorasone
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents
Pteroside A
Eremopetasitenin C3
Pteroside D
Scorzoside
1H-Indazole-1-propanamide,N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2-thienylmethyl)-(9CI)
4-butyl-1,2-diphenylpyrazolidine-3,5-dione, compound with 4,5-dihydrothiazol-2-amine (1:1)
N1-(1-Dimethylcarbamoyl-2-phenyl-ethyl)-2-oxo-N4-(2-pyridin-2-YL-ethyl)-succinamide
Carmoxirole hydrochloride
Carmoxirole hydrochloride (EMD 45609 hydrochloride) is a selective, peripherally acting dopamine D2 receptor agonist and exhibits antihypertensive activities in vivo[1].
Navarixin anhydrous
C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist
(Z)-7-((1R,2R,3R,5S)-2-((E)-3,3-difluoro-4-phenoxybut-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid
(+)-(3R,5S)-fluvastatin
C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AA - Hmg coa reductase inhibitors
2,5-Bis(3,5-dimethyl-1-phenyl-4-pyrazolyl)-1,3,4-oxadiazole
methyl (1R,9S,11S,14E,15S,17S,19R)-19-(acetyloxymethyl)-14-ethylidene-18-oxa-2,12-diazahexacyclo[9.6.1.19,15.01,9.03,8.012,17]nonadeca-3,5,7-triene-19-carboxylate
N-[(E)-{2-[cyclohexyl(methyl)amino]-5-nitrophenyl}methylidene]-2-phenoxyacetohydrazide
N-(2,4-dimethoxyphenyl)-3-(6-methyl-1H-benzimidazol-2-yl)-1-piperidinecarbothioamide
Isobrucine N-oxide
A monoterpenoid indole alkaloid with formula C23H26N2O5, originally isolated from the seeds of Strychnos nux-vomica.
3-(3-ethoxypropyl)-1-[(4-oxo-1H-quinazolin-2-yl)methyl]-1-(phenylmethyl)thiourea
2-cyclopropyl-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]oxan-3-yl]acetamide
2-cyclopropyl-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]acetamide
N-[2-[(2S,5S,6R)-5-(benzylsulfonylamino)-6-(hydroxymethyl)oxan-2-yl]ethyl]cyclobutanecarboxamide
2-cyclopropyl-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]acetamide
2-cyclopropyl-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]oxan-3-yl]acetamide
2-cyclopropyl-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]oxan-3-yl]acetamide
N-[2-[(2R,5S,6R)-5-(benzylsulfonylamino)-6-(hydroxymethyl)oxan-2-yl]ethyl]cyclobutanecarboxamide
N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(phenylmethyl)sulfonylamino]-2-oxanyl]ethyl]cyclobutanecarboxamide
2-cyclopropyl-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]acetamide
2-cyclopropyl-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]acetamide
N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(phenylmethyl)sulfonylamino]-2-oxanyl]ethyl]cyclobutanecarboxamide
N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(phenylmethyl)sulfonylamino]-2-oxanyl]ethyl]cyclobutanecarboxamide
N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(phenylmethyl)sulfonylamino]-2-oxanyl]ethyl]cyclobutanecarboxamide
2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-cyclopropyl-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]acetamide
N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(phenylmethyl)sulfonylamino]-2-oxanyl]ethyl]cyclobutanecarboxamide
N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(phenylmethyl)sulfonylamino]-2-oxanyl]ethyl]cyclobutanecarboxamide
2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
1-[2-(Dimethylamino)ethyl]-4-(5-methylfuran-2-carbonyl)-5-(3-prop-2-enoxyphenyl)pyrrolidine-2,3-dione
19-O-acetylhoerhammericine
An Aspidosperma alkaloid that is hoerhammericine in which the hydroxy group at position 19 has been converted to the corresponding acetate ester. Note the stereoconfiguration of the epoxy group is based on CHEBI:144374, and that of the 19-acetoxy group on the hydroxy group of CHEBI:144372.
3,5-dicyano-4-(dibutylamino)-N-phenylbenzenesulfonamide
6-(2-hydroxyethyl)-2,2,5,7-tetramethyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h-inden-1-one
(4s,4as,5r,6s,8ar,9ar)-4,9a-dimethoxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-6-yl (2z)-3-(methylsulfanyl)prop-2-enoate
(3as,9s,11as)-6,10-dimethyl-3-methylidene-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
methyl 5-hydroxy-10-(hydroxymethyl)-4-[(3-methylbutanoyl)oxy]-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,10h,11h,11ah-cyclodeca[b]furan-6-carboxylate
(3as,11ar)-6-methyl-3-methylidene-10-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
methyl (1r,4s,12r,13r,21s)-7,8-dimethoxy-20-oxo-5,15-diazahexacyclo[11.5.2.1¹,¹².0⁴,¹².0⁶,¹¹.0¹⁵,²¹]henicosa-6,8,10,17-tetraene-4-carboxylate
methyl (14e)-19-[(acetyloxy)methyl]-14-ethylidene-18-oxa-2,12-diazahexacyclo[9.6.1.1⁹,¹⁵.0¹,⁹.0³,⁸.0¹²,¹⁷]nonadeca-3,5,7-triene-19-carboxylate
(1s,6r,8r,11r,12r,13s,23r)-18-methoxy-4-methyl-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-15,17,19-triene-21,24-dione
(1s,2s,3r,4r,5s)-5-ethenyl-3-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl (3s)-3,4-dihydroxy-2-methylidenebutanoate
methyl (2z)-7-(6,7-dimethoxyquinolin-4-yl)-2-ethylidene-6-oxa-4-azatricyclo[5.2.1.0⁴,⁸]decane-10-carboxylate
(5r,6s,7as)-6-ethenyl-3,6-dimethyl-5-(3-{[(2r,4s,5s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}prop-1-en-2-yl)-4,5,7,7a-tetrahydro-1-benzofuran-2-one
methyl 2-{13-formyl-8,16-dimethyl-12-oxo-11-oxa-8,16-diazapentacyclo[7.4.3.2¹⁰,¹³.0¹,⁹.0²,⁷]octadeca-2,4,6-trien-17-yl}but-2-enoate
(3ar,4as,7s,8ar,9ar)-8a-methyl-3,5-dimethylidene-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydronaphtho[2,3-b]furan-2-one
2,19-dimethyl (1s,9r,16s,19r,20r)-21-oxo-2,12-diazahexacyclo[10.6.2.1⁹,¹⁶.0¹,⁹.0³,⁸.0¹⁶,²⁰]henicosa-3,5,7-triene-2,19-dicarboxylate
2,18-dimethyl (1r,9s,16s)-21-oxo-2,12-diazapentacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸]henicosa-3,5,7,17-tetraene-2,18-dicarboxylate
methyl (2e)-2-[(1s,9s,10r,13s,17s)-13-formyl-8,16-dimethyl-12-oxo-11-oxa-8,16-diazapentacyclo[7.4.3.2¹⁰,¹³.0¹,⁹.0²,⁷]octadeca-2,4,6-trien-17-yl]but-2-enoate
methyl (1r,2e,7s,8s,10s)-7-(6,7-dimethoxyquinolin-4-yl)-2-ethylidene-6-oxa-4-azatricyclo[5.2.1.0⁴,⁸]decane-10-carboxylate
(3as,4r,4as,5r,7s,7as,8s,9r,9ar)-4-(acetyloxy)-5,9-dihydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl 2-methylpropanoate
(3s,3as,6ar,8s,9ar,9bs)-3-methyl-6,9-dimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-azuleno[4,5-b]furan-2-one
16-methoxy-4-methyl-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-15(20),16,18-triene-21,24-dione
3-methyl-6,9-dimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-azuleno[4,5-b]furan-2-one
8a,9a-dihydroxy-4-methoxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,9h-naphtho[2,3-b]furan-6-yl 4-hydroxypent-3-enoate
(3s)-3-hydroxy-2,2,5,7-tetramethyl-6-(2-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)-3h-inden-1-one
11ɑ,13-dihydrozaluzanin-C
{"Ingredient_id": "HBIN000278","Ingredient_name": "11\u0251,13-dihydrozaluzanin-C","Alias": "NA","Ingredient_formula": "C21H30O8","Ingredient_Smile": "CC1C2CCC(=C)C3CC(C(=C)C3C2OC1=O)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42851","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β,6β,8α-triacetoxy-4β,5α-epoxy-1-oxo-germacr-10(14)-ene
{"Ingredient_id": "HBIN008101","Ingredient_name": "3\u03b2,6\u03b2,8\u03b1-triacetoxy-4\u03b2,5\u03b1-epoxy-1-oxo-germacr-10(14)-ene","Alias": "NA","Ingredient_formula": "C21H30O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21503","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}